Document:

Exhibit 10.4

 

 

 

Date: March 19, 2019

 

Sukullayanee Suwunnavid

3016 Emporium Suites 622 Sukhumvit 24 Alley,

Klongton Khet Khlong Toei,

Krung Thep Maha Nakhon 10110,

Thailand

RE: CONSULTING AGREEMENT

 

Dear Ms Sukullayanee Suwunnavid,

 

Noble Vici Group, Inc. (the “Corporation”),
Ventrepreneur (SG) Private Limited (“VEPL”) and VenVici Private Limited (“VVPL”) (collectively, “We”)
would like to thank you, Sukullayanee Suwunnavid (“Consultant”) for agreeing to supply certain digital offerings and
services (“Services”) to VVPL’s customers through VEPL. You will supply and provide the fulfilment of our customers
order through your arranged online platform and its related digital offerings.

This letter sets forth our agreement whereby Consultant agrees to accept shares of the Corporation’s common stock, par value
$0.0001 (“Common Stock”), as payment in full for the Services and the satisfaction of all of our obligations under
our arrangement with Consultant with respect to the Services. In determining the amount of shares of Common Stock to be issued,
we have carefully considered a number of factors including our share price and the type and amount of digital products and services
offered, among other things.

 

After due consideration, we hereby offer
to issue Ten Million (10,000,000) shares of the Corporation’s Common Stock, par value $0.0001 (the “Shares”),
at a per share price of US$2.00, as payment in full for the Services and the satisfaction of all of the obligations of the Corporation,
VEPL, VVPL and their affiliates and subsidiaries under our arrangement with Consultant with respect to the Services. We further
agree to register the Shares for on a registration statement with the United States Securities and Exchange Commission within
six (6) months after the date of this letter.

 

The Corporation agrees that Consultant
shall be entitled to engage subcontractors, including without limitation, Fame Reserve Limited, to assist it in providing the Services.

 

If the terms of this letter are acceptable
to you, please indicate your acceptance by your signature below. Thank you for your interest in the Corporation.

 

Yours Sincerely,

 

 

/s/ Eldee Tang

Eldee Tang

Chief Executive Officer & Director

 

 

Noble Vici Group, Inc.

 

 

ACKNOWLEDGED
AND AGREED

 

 

/s/ Sukullayanee
Suwunnavid

Sukullayanee Suwunnavid

 

Dated this 19th
day, March 2019Exhibit
10.1

 

	Mr.
    Anshu Bhatnagar	March
    20, 2019

Chief
Executive Officer

mPhase
Technologies, Inc.

 

Dear
Anshu,

 

Please
accept my resignation as a Director of mPhase Technologies Inc. effective midnight March 20, 2019

 

I
have enjoyed being a Director of the Company. I wish you the best of luck in taking mPhase forward to greater heights.

 

Regards,

 

/s/
Ronald Durando

 

Ronald
A. DurandoExhibit
10.1

 

AMENDED
AND RESTATED EMPLOYMENT AGREEMENT

 

THIS
AMENDED AND RESTATED AGREEMENT (the “Agreement”) is entered into as of March 15, 2019 d between Lishan Aklog MD, residing
at 10 Hickory Pine Court, Purchase, NY 10577 (“Executive”), and PAVmed Inc., a Delaware corporation having its principal
office at One Grand Central Place, Suite 4600, New York, NY 10165 (“Company”) to become effectively immediately;

 

WHEREAS,
the Company and Executive are party to an employment agreement entered into and effective October 24, 2014 (the “Prior Agreement”);

 

WHEREAS,
this Agreement amends and supersedes the Prior Agreement and any other agreement with respect to the matters contained herein.

 

NOW,
THEREFORE, in consideration of the premises and of the mutual covenants and agreements hereinafter set forth, the Company and
the Executive hereby agree as follows:

 

1.
Employment, Duties and Acceptance.

 

1.1
General. The Company hereby agrees to employ the Executive as its Chief Executive Officer (“CEO”) and Chairman
of the Board of Directors (“Chairman”). All of Executive’s powers and authority in any capacity shall at all
times be subject to the direction and control of the Company’s Board of Directors (“Board”). The Board may assign
to Executive such management and supervisory responsibilities and executive duties for the Company or any subsidiary of the Company,
including serving as an executive officer and/or director of any subsidiary, as are consistent with Executive’s status as
Chief Executive Officer and Chairman. The Company and Executive acknowledge that Executive’s primary functions and duties
as Chief Executive Officer shall be general management and control of the affairs and business of the Company.

 

1.2
Duties. Executive accepts such employment and agrees to devote such time as he reasonably deems necessary to the performance
of his duties hereunder. Nothing herein shall be construed as preventing Executive from (i) making and supervising investments
on a personal or family basis (including trusts, funds and investment entities in which Executive or members of his family have
an interest) and (ii) in serving as a consultant to, or on boards of directors of, or in any other capacity to other companies,
for profit and not for profit, provided they will not interfere with the performance of Executive’s duties hereunder or
violate the provisions of Section 5.4 hereof.

 

1.3
Location. Executive will perform his duties in New York, New York. Executive shall undertake such occasional travel, within
or outside the United States, as is reasonably necessary in the interests of the Company.

 

2.
Term. The initial term of this agreement shall commence on March 15, 2019 (the “Effective Date”) and terminate
on the third anniversary of the Effective Date (the “Initial Term”) unless terminated earlier as hereinafter provided
in this Agreement. In addition, the term of this Agreement shall thereafter automatically renew for periods of one-year (the “Renewal
Term”) unless either party gives written notice to the other party at least 60 days prior to the end of the term or at least
60 days prior to any one-year renewal period, that the Agreement shall not be further extended. The period commencing on the Effective
Date and ending on the date on which the term of the Executive’s employment under the Agreement terminates is referred to
herein as the “Term”

 

3.
Compensation and Benefits.

 

3.1
Salary. The Company shall pay to Executive a salary (“Base Salary”) at the annual rate of $431,000. Executive’s
compensation shall be paid in equal, periodic installments in accordance with the Company’s normal payroll procedures.

 

    	 	 	 

    	 	 	 

    

 

3.2
Bonus. In addition to the Base Salary, Executive shall be paid a bonus (“Bonus”) on January 1st
of each year beginning in 2020 equal to 50% of the Base Salary, then in effect, plus additional performance bonuses to be determined
by the Board.3.3 Restrictive Common Stock Awards and Stock Options. The Board (or Compensation Committee) may, in its sole discretion,
grant Employee options to purchase shares of the Company’s common stock from time to time under the Company’s equity
compensation plans, but Executive understands that it is under no obligation to do so. Upon the Effective Date, the Company shall
grant Executive 200,000 shares of the Company’s Restricted Common Stock under the Company’s Second Amended 2014 Long-Term
Incentive Plan (“Plan”). Subject to continued service to the Company through the applicable vesting date and the provisions
of the Plan, the Restricted Common Stock shall become non-forfeitable over three years in equal amounts on each anniversary date.
Any unvested forfeitable shares, shall become immediately vested and non-forfeitable in the event of a termination for Good Reason
or immediately after any Change of Control as defined in the Restricted Common Stock Agreement and Indemnification Agreement.

 

3.4
Benefits. Executive shall be entitled to such medical, life, disability and other benefits as are generally afforded to
other executives of the Company, subject to applicable waiting periods and other conditions, as well as participation in all other
company-wide employee benefits, including a defined contribution pension plan and 401(k) plan, as may be made available generally
to executive employees from time to time. The Executive shall be eligible to participate in the Company’s annual and long-term
incentive plans and programs in accordance with the terms of such plans and programs as in effect and afforded to other senior
executives of the Company at levels determined by the Board (or committee of the Board).

 

3.5
Vacation and Sick Days. Executive shall be entitled to twenty-five (25) days of paid vacation and five (5) days of paid
sick days in each year during the Term and to a reasonable number of other days off for religious and personal reasons in accordance
with customary Company policy.

 

3.6
Expenses. The Company shall pay or reimburse Executive for all transportation, hotel and other expenses reasonably incurred
by Executive on business trips and for all other ordinary and reasonable out-of-pocket expenses actually incurred by him in the
conduct of the business of the Company, including expenses relating to his laptop, cell phone and Blackberry or other similar
devices, against itemized vouchers submitted with respect to any such expenses and approved in accordance with customary procedures.
Reimbursable expenses do not include any expenses in respect of Executive’s commuting transportation or his membership and
activities at the Harvard Club of NY, which are covered by Sections 3.7 and 3.8 below.

 

3.7
Transportation Allowance – The Company shall provide Executive an allowance in the amount of $2,100 per month for commuting
transportation or make direct payments to Executive’s transportation company for up to $2,100 per month to offset the costs
incurred for travel during non-rush hour traffic as a result of limited options to travel to/from Executive’s home base
by public transportation.

 

3.8
Harvard Club expense reimbursement – The Company shall provide Executive an allowance of $1,200 per month to offset the
cost of maintaining his membership and activities at the Harvard Club of NY where the Company frequently engages and hosts potential
customers, vendors, bankers, and other Company related personnel for the benefit of Company related business.

 

4.
Termination.

 

4.1
Death. If Executive dies during the Term, Executive’s employment hereunder shall terminate and the Company shall
pay to Executive’s estate the amount set forth in Section 4.6(a).

 

4.2
Disability. The Company, by written notice to Executive, may terminate Executive’s employment hereunder if Executive
shall fail because of illness or incapacity to render services of the character contemplated by this Agreement for one hundred
eighty (180) days. Upon such termination, the Company shall pay to Executive the amount set forth in Section 4.6(a).

 

    	 	 	 

    	 	 	 

    

 

4.3
By Company for “Cause”. The Company, by written notice to Executive, may terminate Executive’s employment
hereunder for “Cause”. As used herein, “Cause” shall mean: (a) the refusal or failure by Executive to
carry out specific directions of the Board which are of a material nature and consistent with his status as Chief Executive Officer
(or whichever positions Executive holds at such time), or the refusal or failure by Executive to perform a material part of Executive’s
duties hereunder; (b) the commission by Executive of a material breach of any of the provisions of this Agreement; (c) fraud or
dishonest action by Executive in his relations with the Company or any of its subsidiaries or affiliates (“dishonest”
for these purposes shall mean Executive’s knowingly or recklessly making of a material misstatement or omission for his
personal benefit); or (d) the conviction of Executive of a felony under federal or state law. Notwithstanding the foregoing, no
“Cause” for termination shall be deemed to exist with respect to Executive’s acts described in clauses (a) or
(b) above, unless the Company shall have given written notice to Executive within a period not to exceed thirty (30) calendar
days of the initial existence of the occurrence, specifying the “Cause” with reasonable particularity and, within
thirty (30) calendar days after such notice, Executive shall not have cured or eliminated the problem or thing giving rise to
such “Cause;” provided, however, no more than two cure periods need be provided during any twelve-month period. Upon
such termination, the Company shall pay to Executive the amount set forth in Section 4.6(b).

 

4.4
By Executive for “Good Reason”. The Executive, by written notice to the Company, may terminate Executive’s
employment hereunder if a “Good Reason” exists. For purposes of this Agreement, “Good Reason” shall mean
the occurrence of any of the following circumstances without the Executive’s prior written consent: (a) a substantial and
material adverse change in the nature of Executive’s title, duties or responsibilities with the Company that represents
a demotion from his title, duties or responsibilities as in effect immediately prior to such change (such change, a “Demotion”);
(b) material breach of this Agreement by the Company; (c) a failure by the Company to make any payment to Executive when due,
unless the payment is not material and is being contested by the Company, in good faith; (d) a liquidation, bankruptcy or receivership
of the Company; (e) a change in the principal office or work place assigned to the Executive to a location more than 35 miles
distant from its location immediately prior to such change; (f) a material reduction of the Executive’s base salary or bonus
opportunity, unless pursuant to a reduction in such items applicable proportionally to all senior management and board members;
or (g) any reason or no reason following a Change of Control (as defined in the Restricted Common Stock Agreement and the Indemnification
Agreement) and the Executive’s notice of resignation under this subsection is provided to the surviving entity following
a Change of Control within the 60-day period following the closing of the Change of Control. Notwithstanding the foregoing, no
“Good Reason” shall be deemed to exist with respect to the Company’s acts described in clauses (a), (b), (c),
(e), or (f) above, unless Executive shall have given written notice to the Company within a period not to exceed thirty (30) calendar
days of the initial existence of the occurrence, specifying the “Good Reason” with reasonable particularity and, within
thirty (30) calendar days after such notice, the Company shall not have cured or eliminated the problem or thing giving rise to
such “Good Reason”; provided, however, that no more than two cure periods shall be provided during any twelve-month
period of a breach of clauses (a), (b), (c), (e) or (f) above. Upon such termination, the Company shall pay to Executive the amount
set forth in Section 4.6(c).

 

4.5
By Company Without “Cause”. The Company may terminate Executive’s employment hereunder without “Cause”
by giving at least sixty (60) days written notice to Executive. Upon such termination, the Company shall pay to Executive the
amount set forth in Section 4.6(c).

 

    	 	 	 

    	 	 	 

    

 

4.6
Compensation Upon Termination. In the event that Executive’s employment hereunder is terminated, the Company shall
pay to Executive the following compensation:

 

(a)
Payment Upon Death or Disability. In the event that Executive’s employment is terminated pursuant to Sections 4.1
or 4.2, the Company shall no longer be under any obligation to Executive or his legal representatives pursuant to this Agreement
except for: (i) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination; (ii) any Bonus which
would have become payable under Section 3.2 for the year in which the employment was terminated prorated by multiplying the full
amount of the Bonus by a fraction, the numerator of which is the number of “full calendar months” worked by Executive
during the year of termination and the denominator of which is 12 (a “full calendar month” is a month in which the
Executive worked at least two weeks); (iii) all earned and previously approved but unpaid Bonuses for any year prior to the year
of termination; (iv) all valid expense reimbursements, and (v) all accrued but unused vacation pay.

 

(b)
Payment Upon Termination by the Company For “Cause”. In the event that the Company terminates Executive’s
employment hereunder pursuant to Section 4.3, the Company shall have no further obligations to the Executive hereunder, except
for: (i) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination (ii) all valid expense reimbursements
and (iii) all unused vacation pay through the date of termination required by law to be paid.

 

(c)
Payment Upon Termination by Company Without Cause or by Executive for Good Reason. In the event that Executive’s
employment is terminated pursuant to Sections 4.4 or 4.5, the Company shall have no further obligations to Executive hereunder
except for: (i) 100% of the Base Salary due Executive pursuant to Section 3.1 hereof for twelve (12) months or twenty-four (24)
months in the event of a Change of Control that occurred within 60 days of termination, payable in full; (ii) any Bonus which
would have become payable under Section 3.2 for the year in which the employment was terminated prorated by multiplying the full
amount of the Bonus by a fraction, the numerator of which is the number of “full calendar months” worked by Executive
during the year of termination and the denominator of which is 12 (a “full calendar month” is a month in which the
Executive worked at least two weeks); (iii) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination;
(iv) all valid expense reimbursements; (v) all accrued but unused vacation pay and (vi) to the extent the Executive timely elects
to receive continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”),
the Company shall pay or reimburse the Executive, on a monthly basis, an amount equal to the full monthly premium for such coverage,
from the date of termination until the earlier of (A) the date twelve (12) months following the date of termination, and (B) the
date of Executive becoming eligible for coverage under a new employer’s health insurance plan (the COBRA health care continuation
coverage period under Section 4980B of the Internal Revenue Code of 1986, as amended (the “Code”) shall run concurrently
with the foregoing period), subject, in the case of clause (i) and (ii), to Executive’s compliance with Section 5 and to
Executive’s execution of a release of claims in favor of the Company, its affiliates and their respective officers and directors
in a form provided by the Company and such release becoming effective,.

 

(d)
Executive shall have no duty to mitigate awards paid or payable to him pursuant to this Agreement, and any compensation paid or
payable to Executive from sources other than the Company will not offset or terminate the Company’s obligation to pay to
Executive the full amounts pursuant to this Agreement.

 

5.
Protection of Confidential Information; Non-Competition.

 

5.1
Acknowledgment. Executive acknowledges that:

 

(a)
As a result of his current and prior employment with the Company, Executive has obtained and will obtain secret and confidential
information concerning the business of the Company and its subsidiaries (referred to collectively in this Section 5 as the “Company”),
including, without limitation, financial information, proprietary rights, trade secrets and “know-how,” customers
and sources (“Confidential Information”).

 

    	 	 	 

    	 	 	 

    

 

(b)
The Company will suffer substantial damage which will be difficult to compute if, during the period of his employment with the
Company or thereafter, Executive should enter a business competitive with the Company or divulge Confidential Information.

 

(c)
The provisions of this Agreement are reasonable and necessary for the protection of the business of the Company.

 

5.2
Confidentiality. Executive agrees that he will not at any time, during the Term or thereafter, divulge to any person or
entity any Confidential Information obtained or learned by him as a result of his employment with the Company, except (i) in the
course of performing his duties hereunder, (ii) with the Company’s prior written consent; (iii) to the extent that any such
information is in the public domain other than as a result of Executive’s breach of any of his obligations hereunder; or
(iv) where required to be disclosed by law, regulation, stock exchange rule, court order, subpoena or other government process.
If Executive shall be required to make disclosure pursuant to the provisions of clause (iv) of the preceding sentence, Executive
promptly, but in no event more than 48 hours after learning of such subpoena, court order, or other government process, shall
notify, confirmed by mail, the Company and, at the Company’s expense, Executive shall: (a) take all reasonably necessary
and lawful steps required by the Company to defend against the enforcement of such subpoena, court order or other government process,
and (b) permit the Company to intervene and participate with counsel of its choice in any proceeding relating to the enforcement
thereof.

 

5.3
Documents. Upon termination of his employment with the Company, Executive will promptly deliver to the Company all memoranda,
notes, records, reports, manuals, drawings, blueprints and other documents (and all copies thereof) relating to the business of
the Company and all property associated therewith, which he may then possess or have under his control; provided, however, that
Executive shall be entitled to retain copies of such documents reasonably necessary to document his financial relationship with
the Company.

 

5.4
Non-competition. During the Term and for a period of one (1) year thereafter, or two (2) years thereafter in the event
of a Change of Control Executive, without the prior written permission of the Company, shall not, anywhere in the world, (i) be
employed by, or render any services to, any person, firm or corporation engaged in the medical device industry or any other business
which is directly in competition with any “material” business conducted by the Company or any of its subsidiaries
at the time of termination (as used herein “material” means a business which generated at least 10% of the Company’s
consolidated revenues for the last full fiscal year for which audited financial statements are available) (“Competitive
Business”); (ii) engage in any Competitive Business for his or its own account; (iii) be associated with or interested in
any Competitive Business as an individual, partner, shareholder, creditor, director, officer, principal, agent, employee, trustee,
consultant, advisor or in any other relationship or capacity; (iv) employ or retain, or have or cause any other person or entity
to employ or retain, any person who was employed or retained by the Company while Executive was employed by the Company (other
than Executive’s personal secretary and assistant); or (v) solicit, interfere with, or endeavor to entice away from the
Company, for the benefit of a Competitive Business, any of its customers or other persons with whom the Company has a contractual
relationship. Notwithstanding the foregoing, nothing in this Agreement shall preclude Executive from investing his personal assets
in any manner he chooses, provided, however, that Executive may not, during the period referred to in this Section 5.4, own more
than 4.9% of the equity securities of any Competitive Business.

 

5.5
Injunctive Relief. If Executive commits a breach, or threatens to commit a breach, of any of the provisions of Sections
5.2 or 5.4, the Company shall have the right and remedy to seek to have the provisions of this Agreement specifically enforced
by any court having equity jurisdiction, it being acknowledged and agreed by Executive that the services being rendered hereunder
to the Company are of a special, unique and extraordinary character and that any such breach or threatened breach will cause irreparable
injury to the Company and that money damages will not provide an adequate remedy to the Company. The rights and remedies enumerated
in this Section 5.5 shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under
law or equity. In connection with any legal action or proceeding arising out of or relating to this Agreement, the prevailing
party in such action or proceeding shall be entitled to be reimbursed by the other party for the reasonable attorneys’ fees
and costs incurred by the prevailing party.

 

    	 	 	 

    	 	 	 

    

 

5.6
Modification. If any provision of Sections 5.2 or 5.4 is held to be unenforceable because of the scope, duration or area
of its applicability, the tribunal making such determination shall have the power to modify such scope, duration, or area, or
all of them, and such provision or provisions shall then be applicable in such modified form.

 

5.7
Survival. The provisions of this Section 5 shall survive the termination of this Agreement for any reason, except in the
event Executive is terminated by the Company without “Cause,” or if Executive terminates this Agreement with “Good
Reason,” (Good Reason for purposes of this Section shall not include termination for Good Reason defined in Section 4.4
(g) in connection with a Change of Control and while Executive is receiving payments in accordance with Section 4.6 (c)) in either
of which events, clauses (i), (ii) and (iii) of Section 5.4 shall be null and void and of no further force or effect.

 

6.
Miscellaneous Provisions.

 

6.1
Notices. All notices provided for in this Agreement shall be in writing, and shall be deemed to have been duly given when
(i) delivered personally to the party to receive the same, or (ii) when mailed first class postage prepaid, by certified mail,
return receipt requested, addressed to the party to receive the same at his or its address set forth below, or such other address
as the party to receive the same shall have specified by written notice given in the manner provided for in this Section 6.1.
All notices shall be deemed to have been given as of the date of personal delivery or mailing thereof.

 

If
to Executive:

Lishan
Aklog, M.D.

10
Hickory Pine Court

Purchase,
NY 10577

 

If
to the Company:

PAVmed
Inc.

One
Grand Central Place, Suite 4600

New
York, NY 10165

With
a copy in either case to:

Graubard
Miller

The
Chrysler Building

405
Lexington Ave, 11th Floor

New
York, NY 10170

 

6.2
Entire Agreement; Waiver. This Agreement and the Restricted Common Stock Award sets forth the entire agreement of the parties
relating to the employment of Executive and is intended to supersede all prior negotiations, understandings and agreements. No
provisions of this Agreement may be waived or changed except by a writing by the party against whom such waiver or change is sought
to be enforced. The failure of any party to require performance of any provision hereof or thereof shall in no manner affect the
right at a later time to enforce such provision.

 

6.3
Governing Law. All questions with respect to the construction of this Agreement, and the rights and obligations of the
parties hereunder, shall be determined in accordance with the law of the State of New York applicable to agreements made and to
be performed entirely in New York.

 

    	 	 	 

    	 	 	 

    

 

6.4
Binding Effect; Non-assignability. This Agreement shall inure to the benefit of and be binding upon the successors and
assigns of the Company. This Agreement shall not be assignable by Executive, but shall inure to the benefit of and be binding
upon Executive’s heirs and legal representatives.

 

6.5
Severability. Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement
shall be affected, and this Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.

 

6.6
Section 409A. This Agreement is intended to comply with the provisions of Section 409A of the Internal Revenue Code (“Section
409A”). To the extent that any payments and/or benefits provided hereunder are not considered compliant with Section 409A,
the parties agree that the Company shall take all actions necessary to make such payments and/or benefits become compliant.

 

7.
Arbitration; Expenses.

 

In
the event of any dispute under the provisions of this Agreement, other than a dispute in which the primary relief sought is an
equitable remedy such as an injunction, the parties shall be required to have the dispute, controversy or claim settled by arbitration
in the non-moving parties jurisdiction in accordance with the Employment Arbitration Rules and Mediation Procedures then in effect
of the American Arbitration Association, before an arbitrator agreed to by both parties. If the parties cannot agree upon the
choice of arbitrator, the Company and the Executive will each choose an arbitrator. The two arbitrators will then select a third
arbitrator who will serve as the actual arbitrator for the dispute, controversy or claim. Any award entered by the arbitrator
shall be final, binding and nonappealable and judgment may be entered thereon by either party in accordance with applicable law
in any court of competent jurisdiction. This arbitration provision shall be specifically enforceable. The arbitrator shall have
no authority to modify any provision of this Agreement or to award a remedy for a dispute involving this Agreement other than
a benefit specifically provided under or by virtue of the Agreement. Each party shall be responsible for its own expenses relating
to the conduct of the arbitration (including reasonable attorneys’ fees and expenses) and shall share the fees of the American
Arbitration Association.

 

8.
Attorneys’ Fees.

 

Except
as provided in Section 7 above, in any action at law or in equity to enforce or construe any provisions or rights under this Agreement,
the unsuccessful party or parties to such litigation, as determined by the courts pursuant to a final judgment or decree, shall
pay the successful party or parties all costs, expenses, and reasonable attorneys’ fees incurred by such successful party
or parties (including, without limitation, such costs, expenses, and fees on any appeals), and if such successful party or parties
shall recover judgment in any such action or proceedings, such costs, expenses, and attorneys’ fees shall be included as
part of such judgment.

 

[Signature
page follows:]

 

    	 	 	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

 

	 	PAVMED INC.
	 	 	 
	 	By:	/s/
    Ronald M. Sparks
	 	Name: 	Ronald
    M. Sparks
	 	Title:	Chairman
    of Compensation Committee
	 	 	 
	 	 	/s/
    Lishan Aklog, M.D.
	 	 	Lishan
    Aklog, M.D.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}]]